Meulen Lonne W T, Bogie Roel M M, Siersema Peter D, Winkens Bjorn, Vlug Marije S, Wolfhagen Frank H J, Baven-Pronk Martine A M C, van der Voorn Michael P J A, Schwartz Matthijs P, Vogelaar Lauran, Seerden Tom C J, Hazen Wouter L, Schrauwen Ruud W M, Herrero Lorenza Alvarez, Schreuder Ramon-Michel, van Nunen Annick B, de Bruin Gijs J, Marsman Willem A, de Bièvre Marc, Roomer Robert, de Ridder Rogier J J, Pellisé Maria, Bourke Michael J, Masclee Ad A M, Moons Leon M G
Department of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.
GROW, School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Endoscopy. 2025 Jun;57(6):620-628. doi: 10.1055/a-2498-7114. Epub 2024 Dec 9.
Piecemeal endoscopic mucosal resection (EMR) of large (≥ 20 mm) nonpedunculated colorectal polyps (LNPCPs) is succeeded by a 6-month surveillance endoscopy to evaluate the post-EMR scar for recurrence. Data from expert centers suggest that routine tattoo placement and scar biopsies can be omitted, but data from community hospitals are lacking.
The agreement between optical assessment and histological confirmation by routine biopsies was evaluated in a post-hoc analysis of the STAR-LNPCP study (NTR7477), containing prospective data on 6-month post-EMR scar assessments in 30 Dutch community hospitals (October 2019 to May 2022). A standardized protocol was followed for documentation of optical characteristics, imaging, and biopsy of the post-EMR scar. RESULTS : In 1277 post-EMR scar assessments, identification of the scar was achieved in 1215/1277 (95 %). Tattoo placement did not influence scar identification. Scar biopsy was performed in 1050/1215 cases (86 %). Recurrences were seen in 200/1050 cases (19 %). There was good agreement between optical assessment of recurrence and histological confirmation (Cohen's kappa 0.78 [95 %CI 0.73-0.83]). The negative and positive predictive values were 98 % (95 %CI 97 %-99 %) and 74 % (95 %CI 68 %-80 %), respectively. A higher false-positive rate was seen after prior use of clips (11 % vs. 5 %; = 0.02). Dedicated endoscopists identified the scar more often (96 % vs. 88 %; < 0.001), and showed a lower optical recurrence miss rate (1 % vs. 3 %; = 0.11) compared with nondedicated endoscopists. CONCLUSION : Based on this multicenter community hospital study, routine tattoo placement and scar biopsies of the post-EMR scar can be omitted. Assessment of post-EMR scars by dedicated endoscopists is advised.
对于大型(≥20mm)无蒂结直肠息肉(LNPCPs)进行内镜下黏膜分片切除术(EMR)后,需进行为期6个月的监测性内镜检查,以评估EMR术后瘢痕是否复发。来自专家中心的数据表明,常规纹身定位和瘢痕活检可以省略,但社区医院的数据尚缺。
在STAR-LNPCP研究(NTR7477)的事后分析中,评估了光学评估与常规活检组织学确认之间的一致性,该研究包含了荷兰30家社区医院(2019年10月至2022年5月)关于EMR术后6个月瘢痕评估的前瞻性数据。遵循标准化方案记录EMR术后瘢痕的光学特征、成像和活检情况。
在1277次EMR术后瘢痕评估中,1215/1277(95%)能够识别出瘢痕。纹身定位不影响瘢痕识别。1050/1215例(86%)进行了瘢痕活检。200/1050例(19%)出现复发。复发的光学评估与组织学确认之间具有良好的一致性(Cohen's kappa系数为0.78 [95%CI 0.73 - 0.83])。阴性和阳性预测值分别为98%(95%CI 97% - 99%)和74%(95%CI 68% - 80%)。先前使用夹子后假阳性率更高(11%对5%;P = 0.02)。与非专业内镜医师相比,专业内镜医师更常识别出瘢痕(96%对88%;P < 0.001),且光学复发漏诊率更低(1%对3%;P = 0.11)。
基于这项多中心社区医院研究,EMR术后瘢痕的常规纹身定位和瘢痕活检可以省略。建议由专业内镜医师评估EMR术后瘢痕。